Business
How Is Rallybio Corp.(NASDAQ: RLYB) Is Expected To Perform In The Next Few Months?
Rallybio Corp (NASDAQ:RLYB) has a beta value of -1.49 and has seen 53831.0 shares traded in the last trading session. The company, currently valued at
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
